BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Cytiva boosts process efficiency with X-platform bioreactors.

Global biotechnology leader builds on Xcellerex heritage to now offer X-platform bioreactors. X-platform bioreactors can be used for monoclonal antibodi...

April 19, 2023 | News

Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses

"This collaboration represents an exciting opportunity for Nona Biosciences to leverage its fully human antibody H2L2 transgenic mice, together with the te...

April 19, 2023 | News

BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases

BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...

April 18, 2023 | News

Shanghai Biopharma Presents Phase I Data for Novel CAR-T in Advanced Liver Cancer

Early results indicate that C-CAR031 is well tolerated with promising anti-tumor activity seen and objective responses in several patients to date, includi...

April 18, 2023 | News

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees and Opens Spring 2023 Submissions

In support of global initiatives to advance molecular profiling in oncology, Thermo Fisher Scientific today announced the latest recipients of the&nb...

April 17, 2023 | News

Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye

A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...

April 17, 2023 | News

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab)

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for...

April 17, 2023 | News

AffaMed Therapeutics Approved for Phase 3 Trial of DEXTENZA® in China for Eye Surgery Inflammation and Pain

In addition, AffaMed is pleased to announce that DEXTENZA has recently been approved in Macau, China for the treatment of ocular itchin...

April 17, 2023 | News

Anika Enters Into Cooperation Agreement with Caligan Partners

As part of the agreement, the Company appointed Gary Fischetti as a Class III director. Fischetti will join two existing board members on a newly formed Ca...

April 14, 2023 | News

Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions

The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies Evonik recognized for high-quality Cell Culture Sol...

April 13, 2023 | News

Discovery Life Sciences Acquiert Reachbio Research Labs

Discovery Life Sciences™ (Discovery), Biospecimen and Biomarker Specialists, has acquired Seattle-based ReachBio Research L...

April 12, 2023 | News

Boan Biotech's Biologics License Application for Boyounuo® (Bevacizumab Injection) Accepted in Brazil

Envisioned to be "a leading global biopharmaceutical company", Boan Biotech develops biologics for both Chinese and international markets, including E...

April 12, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

April 12, 2023 | News

JW Therapeutics' Relma-cel approved for systemic lupus erythematosus trial.

SLE is a complex autoimmune disease with diverse clinical manifestations involving many organs and systems. It is estimated that China has 1 mill...

April 11, 2023 | News

Stay Connected